Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using theemail support widget if the problem persists.
Kits Eyecare Ltd. operates a digital eyecare platform in the United States and Canada. It manufactures progressive and contact lenses, eyeglasses, and...
Latest Report
5 Mar 2025Next Earnings
9 May 2025Search metric that you want to observe. Create your own widget, customise and rearrange metrics
Metric Name | Value | Trend |
---|---|---|
Dividend Yield | 0.0% | |
P/E Ratio | 107.3x | |
Revenue | 110.8 M | |
Net Income to Company | 2.167 M |
No data available
10Y DCF EBITDA ExitView Updated 32 minutes ago |
10Y DCF Revenue ExitView Updated 32 minutes ago |
10Y DCF Growth ExitView Updated 32 minutes ago |
5Y DCF EBITDA ExitView Updated 30 minutes ago |
5Y DCF Revenue ExitView Updated 32 minutes ago |
5Y DCF Growth ExitView Updated 32 minutes ago |
DuPont ROE AnalysisView Updated 4 days ago |
10Y Historical FinancialsView Updated 4 days ago |
5Y Historical FinancialsView Updated 4 days ago |
EV / EBIT MultiplesView Updated 32 minutes ago |
EV / EBITDA MultiplesView Updated 32 minutes ago |
P/E MultiplesView Updated 32 minutes ago |
Price / Book MultiplesView Updated 32 minutes ago |
Price / Sales MultiplesView Updated 32 minutes ago |
EV / Revenue MultiplesView Updated 32 minutes ago |
CAPM WACC ModelView Updated 12 hours ago |
Earnings Power ValueView Updated 32 minutes ago |
(USD in millions) | Trailing Twelve Months | Fiscal Quarters | |||
---|---|---|---|---|---|
Period Ending | Dec-22 | Dec-23 | Dec-24 | Dec-23 | Dec-24 |
Income Statement | |||||
Revenue | 68 | 91 | 111 | 24 | 31 |
Operating Income | (4.95) | (1.08) | 1.91 | (0.04) | 1.48 |
Net Profit | (3.36) | (1.67) | 2.17 | (0.37) | 1.90 |
Diluted EPS | -0.11 | -0.053 | 0.063 | -0.015 | 0.055 |
EBITDA | (3.21) | 0.64 | 3.13 | 0.32 | 1.79 |
Balance Sheet | |||||
Cash & ST Invest. | 14 | 12 | 13 | 12 | 13 |
Current Assets | 27 | 26 | 31 | 26 | 31 |
Total Assets | 69 | 66 | 72 | 66 | 72 |
Current Liabilities | 18 | 19 | 27 | 19 | 27 |
Total Liabilities | 30 | 27 | 31 | 27 | 31 |
Total Equity | 40 | 39 | 40 | 39 | 40 |
Total Debt | 14 | 12 | 8.76 | 12 | 8.76 |
Cash Flow Statement | |||||
Cash Flow Operations | 3.45 | 1.82 | 9.07 | (1.76) | 2.64 |
Cash From Investing | (0.19) | (0.42) | (2.19) | (0.12) | (0.76) |
Cash From Financing | (3.79) | (3.83) | (3.49) | (0.91) | (0.94) |
Free Cash Flow | 3.26 | 1.39 | 6.87 | (1.89) | 1.88 |